Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: BAY86-5300
Total 0 results
Nothing found
Sponsors and Collaborators
Aga Khan Foundation, Pakistan
Phramongkutklao College of Medicine and Hospital
Department of Anesthesiology, North Denmark Regional Hospital
YASEMİN AYDIN KARTAL
Alessandra Palo
Grünenthal Denmark ApS
Irish Endocrine Society
CeRSM
Gregorio Covino
Invicta Medical Inc.
Yancheng City NO.1 People's Hospital
Sichuan Haisco Pharmaceutical Group Co., Ltd
Outpatient Endovascular and Interventional Society
CARITAS Rundum zu Hause betreut
Eastman Kodak Company
Erzurum Regional Training & Research Hospital
Axon Neuroscience SE
Doterra Healing Hands Foundation
Saint Pierre Institute - Palavas les Flots
EMET Pharmaceuticals, LLC
View Full List
Medical Conditions
Retroperitoneal Disease
Blood Sampling
Chemotherapy-induced Febrile Neutropenia (FN)
Joint Arthroplasty
Desquamative Interstitial Pneumonia
Etomidate Overdose of Undetermined Intent
MEK Inhibitor-Associated Serous Retinopathy
Refractory Malignant Skin Neoplasm
Lip and Oral Cavity Cancer
Contingent Versus Noncontingent Incentives
Fibromyoma;Cervix
Corticobasal Degeneration
B-cell Acute Lymphoblastic Leukemia
Adult Myxopapillary Ependymoma
Documented Silent Ischemia
Animal-assisted Intervention
Shoulder Arthropathy
Cough Variant Asthma
Canaloplasty
Active Cocaine Users
View Full List
Drug Interventions
Ranitidine
LY2216684
Anti-PD1 antibody, nimotuzumab and capecitabine
Neridronate
Apatinib
Betamethasone
Test varnish
Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
Systemic intravenous lidocaine infusion
Carbetocin
MYL-1501D product using manufacture process VI
Leuprolide acetate 11.25 mg
Niraparib
Pacritinib
Risperidone
Amantadine Sulfate
Enteral oxygen therapy
Lenalidomide
Pregabalin
Naltrexone 50 Mg + Inactive Marijuana (0% THC)
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Algeria
Contract Research Organizations in Estonia
Contract Research Organizations in Gambia
Contract Research Organizations in India
Contract Research Organizations in Italy
Contract Research Organizations in Kosovo
Contract Research Organizations in Latvia
Contract Research Organizations in Mozambique
Contract Research Organizations in Romania
Contract Research Organizations in Senegal
Contract Research Organizations in Sweden
Contract Research Organizations in Ukraine
CRO list by country
CROs in Rwanda
ACROSS Global
All CROs in Rwanda
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe